Press Releases

ObsEva SA to Participate in JP Morgan Healthcare Conference January 7-10, 2019

January 2, 2019

Geneva, Switzerland and Boston – January 2, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of…

Read more

Sign up for news


* Type:

InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther

Read our privacy policy here.